MINNEAPOLIS , Sept. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual meeting of the Society for Neuroscience (SfN) at Neuroscience 2024, taking place October 5-9, 2024 , in Chicago, Illinois . At booth #1165, Bio-Techne will feature its market-leading portfolio of high-quality life science reagents, immunoassays, automated proteomic analytical instruments, and multiomics solutions.
These technologies are accelerating research by streamlining biomarker discovery and quantification, optimizing neural cell cultures and organoid models, and transforming drug discovery and screening processes. In a nanosymposium, Bio-Techne will discuss a study investigating senescence in the aging brain, highlighting the novel RNAscopeTM Multiomic LS assay for high-throughput spatial analysis. Additionally, the team will present a poster detailing Bio-Techne's commitment to antibody validation for use on COMET TM , the fully automated, high-throughput, hyperplex spatial biology platform from Lunaphore TM , a Bio-Techne brand.
Bio-Techne will also host a Product Theater presentation in collaboration with FUJIFILM Cellular Dynamics, Inc. The presentation will focus on intracellular signaling in Alzheimer's disease, including the use of Simple WesternTM automated western technology for protein size characterization and quantification directly in complex samples like cell .
